Regeneron Pharmaceuticals, Inc. REGN
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. The company focuses on developing monoclonal antibody therapies and other biologics to treat conditions in key therapeutic areas including ophthalmology, immunology and inflammation, oncology, and cardiovascular/metabolic diseases. Regeneron serves patients, healthcare providers, and healthcare systems globally through its innovative product portfolio and collaborative partnerships with other pharmaceutical companies. Its business model combines proprietary technology platforms like VelocImmune for antibody discovery with strategic collaborations for development and commercialization, generating revenue from product sales, collaboration profits, and royalties.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.